Bristol-Myers Squibb Insider Trades

BMY

Track insider trading activity from Bristol-Myers Squibb executives and directors. See which insiders are buying and selling BMY stock.

Trades Last 12 Months

BMY Price

All Insider Trades for Bristol-Myers Squibb

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Gallman Cari Evp, General Counsel
Holding Value $1.15M 18,208 shares
Last Trade
Oct 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$279k 4,559 shares
$61.15
$63.02
Holding Value $1.07M 17,050 shares
Last Trade
Sep 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.9k 560 shares
$62.40
$63.02
Arduini Peter J Director
Holding Value $4.67M 74,077 shares
Last Trade
Sep 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.9k 560 shares
$62.40
$63.02
Yale Phyllis R Director
Holding Value $2.9M 45,980 shares
Last Trade
Sep 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.9k 560 shares
$62.40
$63.02
Rice Derica W Director
Holding Value $2.65M 42,084 shares
Last Trade
Sep 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$38.7k 620 shares
$62.40
$63.02
Holding Value $4.53M 71,859 shares
Last Trade
Sep 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.2k 821 shares
$62.40
$63.02
Massacesi Cristian Evp,chief Med Offr,head Of Dev
Holding Value $1.18M 18,748 shares
Last Trade
Sep 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$403k 6,249 shares
$64.57
$63.02
Short Bartie Wendy Evp, Corporate Affairs
Holding Value $839k 13,317 shares
Last Trade
Sep 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$82.7k 1,236 shares
$66.92
$63.02
Holzer Phil M SVP And Controller
Holding Value $1.06M 16,862 shares
Last Trade
Aug 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$33.8k 500 shares
$67.50
$63.02
Haller Julia A Director
Holding Value $0 0 shares
Last Trade
Jun 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.1M 20,460 shares
$53.76
$63.02
Lenkowsky Adam Evp, Chief Commercial Officer
Holding Value $1.28M 20,305 shares
Last Trade
May 01, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$11.8k 203 shares
$58.22
$63.02
Shanahan Karin Evp, Chief Supply Chain & Ops
Holding Value $1.63M 25,888 shares
Last Trade
Apr 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$104k 1,692 shares
$61.73
$63.02
Elkins David V Evp, Chief Financial Officer
Holding Value $10.3M 163,729 shares
Last Trade
Apr 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.85M 30,000 shares
$61.67
$63.02
Holding Value $4.33M 68,727 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.2k 845 shares
$60.65
$63.02
Holding Value $980k 15,556 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35k 577 shares
$60.65
$63.02
Yale Phyllis R Director
Holding Value $2.77M 43,903 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35k 577 shares
$60.65
$63.02
Boerner Christopher S. Chief Executive Officer
Holding Value $1.64M 26,083 shares
Last Trade
Mar 10, 2026 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$525k 8,734 shares
$60.13
$63.02
Hickey Benjamin President, Rayzebio Org.
Holding Value $1.08M 17,143 shares
Last Trade
Mar 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.72M 28,572 shares
$60.13
$63.02
Plenge Robert M Evp, Chief Research Officer
Holding Value $148k 2,342 shares
Last Trade
Mar 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 17,501 shares
$60.13
$63.02
Hoch Lynelle President, Cell Therapy Org.
Holding Value $770k 12,217 shares
Last Trade
Mar 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$493k 8,192 shares
$60.13
$63.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up